about
A novel human stress response-related gene with a potential role in induced radioresistanceAlterations in the steroid hormone receptor co-chaperone FKBPL are associated with male infertility: a case-control study.FKBPL regulates estrogen receptor signaling and determines response to endocrine therapy.Gene regulation by low-dose ionizing radiation in a normal human lung epithelial cell line.The anti-migratory effects of FKBPL and its peptide derivative, AD-01: regulation of CD44 and the cytoskeletal pathway.FKBPL and peptide derivatives: novel biological agents that inhibit angiogenesis by a CD44-dependent mechanism.Vasoactivity of rucaparib, a PARP-1 inhibitor, is a complex process that involves myosin light chain kinase, P2 receptors, and PARP itself.FKBPL is a critical antiangiogenic regulator of developmental and pathological angiogenesis.FKBPL: a marker of good prognosis in breast cancer.Gene-directed enzyme prodrug therapy: a current assessment.Targeting nitric oxide for cancer therapy.Nitrosative stress in cancer therapy.Delivering a research-enabled multistakeholder partnership for enhanced patient care at a population level: The Northern Ireland Comprehensive Cancer ProgramRALA-mediated delivery of FKBPL nucleic acid therapeuticsNitric oxide--a novel therapeutic for cancer.Vasoactivity of AG014699, a clinically active small molecule inhibitor of poly(ADP-ribose) polymerase: a contributory factor to chemopotentiation in vivo?Nitrosative stress as a mediator of apoptosis: implications for cancer therapy.Systemic RALA/iNOS Nanoparticles: A Potent Gene Therapy for Metastatic Breast Cancer Coupled as a Biomarker of Treatment.Nitric oxide physiology and pathology.The emerging role of FK506-binding proteins as cancer biomarkers: a focus on FKBPL.The therapeutic and diagnostic potential of FKBPL; a novel anticancer protein.The Role of Peptidyl Prolyl Isomerases in Aging and Vascular Diseases.Relationship between clonogenic radiosensitivity, radiation-induced apoptosis and DNA damage/repair in human colon cancer cellsPotential use of the alkaline comet assay as a predictor of bladder tumour response to radiationDNA vaccination for cervical cancer; a novel technology platform of RALA mediated gene delivery via polymeric microneedles.Potentiating the Anticancer Properties of Bisphosphonates by Nanocomplexation with the Cationic Amphipathic Peptide, RALA.Transcending epithelial and intracellular biological barriers; a prototype DNA delivery device.Development of TMTP-1 targeted designer biopolymers for gene delivery to prostate cancer.Development and characterization of self-assembling nanoparticles using a bio-inspired amphipathic peptide for gene delivery.Identification of RBCK1 as a novel regulator of FKBPL: implications for tumor growth and response to tamoxifen.The contribution of N₂O₃ to the cytotoxicity of the nitric oxide donor DETA/NO: an emerging role for S-nitrosylation.Gamma irradiation and targeted radionuclides enhance the expression of the noradrenaline transporter transgene controlled by the radio-inducible p21(WAF1/CIP1) promoter.Cytochrome P450 1B1 mRNA untranslated regions interact to inhibit protein translation.Evaluation of a multi-functional nanocarrier for targeted breast cancer iNOS gene therapy.Nitric oxide synthase gene therapy enhances the toxicity of cisplatin in cancer cells.The tissue plasminogen activator gene promoter: a novel tool for radiogenic gene therapy of the prostate?Hypoxia selects for androgen independent LNCaP cells with a more malignant geno- and phenotype.The radiation-inducible pE9 promoter driving inducible nitric oxide synthase radiosensitizes hypoxic tumour cells to radiation.Human osteocalcin: a strong promoter for nitric oxide synthase gene therapy, with specificity for hormone refractory prostate cancer.p21((WAF1))-mediated transcriptional targeting of inducible nitric oxide synthase gene therapy sensitizes tumours to fractionated radiotherapy.
P50
Q22010661-CFF81440-FADF-49B2-B3CE-4D4CDDB150C8Q33748915-ADE5D05F-FDB1-41D3-BF59-E9404AA4C4C7Q34094990-32F0E0FD-7215-4B33-BF4B-CCFFC84E43FAQ34418642-D9CD2B45-9025-483F-BF34-C9E9766C93F4Q34606294-379D8FE0-A800-4EFC-B9B3-479A98B522DFQ34688048-2E5C2A7D-73EA-46EE-A70F-C32A4ED753B2Q35092269-1D5C1CBC-68AD-42EB-81C8-2D62150ED7E7Q35558306-BB19DCB0-6B3E-4170-984A-60D5BB01C5B5Q35828542-E00B56E9-EF29-4A81-BF84-00DAE986E052Q35910832-6DB280A2-610E-44C1-AE1F-90AAB3DD448BQ36709690-E730FDC3-0B66-4BA7-BA6C-42E261F46590Q36813746-9DAEEC6D-C114-4019-8FAF-CC30F085895EQ36893736-9CEA5C57-D00E-49CF-A332-4338236EE01FQ37013400-C180AB6C-3502-486B-B330-66EC442EB44DQ37166124-9EE4B2AC-9E98-4618-B8D7-6C692FD9EBBAQ37373632-F92917BF-1221-473B-BD78-950CBC711974Q37705536-D01BFA43-E55F-4904-92F8-BFF612DF1D40Q37718207-16753F59-643A-4C72-A5E0-41C9BF45956DQ37821369-D6DA2A94-D0AE-4A2F-A55C-8C277B5D3BCEQ37856424-43516784-04D4-4F62-9005-4335EC2E514CQ37977747-B8923C86-5E85-4AF2-B3A9-C607FA66965BQ38489354-51F2DDB0-52BB-4BA4-B84B-6709E0FE45C6Q38611240-4925A125-9776-4B4D-B593-EAE4360AF24FQ38611330-37AAF67A-B15C-4FC2-9197-B0DED551450DQ38726068-21E2F320-176E-4CDF-8E27-5B6A9908860BQ38787925-1D6E2DBD-FD0A-4FA9-B4E1-4775F9BE65E7Q38793709-FC414DE4-5CE6-4B94-B4D6-75D88E0E0888Q38800195-BB9DAF8D-BE01-43DB-BCD2-22CEA54E7434Q38978014-82243417-7ED9-40F1-8CA0-3C26C8349EA5Q39115878-C5EF5705-6195-4D44-95B7-8DEC8E6F4B0EQ39196011-7FED34B8-BA38-493E-96FB-053132D9785DQ39207425-0BCFD6F5-F651-4B5B-B151-E5B096191F1DQ39775821-279CAD8E-3D53-45CA-8679-FF6EFDD15552Q39809082-BB9354AE-9F96-4C86-924B-BF5970BDE5F5Q39907940-8269F56F-50BA-490B-8397-6986F21B72BEQ39963103-6ABD5375-80BC-45F2-8CED-DB778898A181Q39977133-3B2A5928-1EA4-4F6D-9497-84B6E213145AQ40015618-9E65834D-DC2F-4CDB-8243-EA8962B5E128Q40138750-E818E9B0-343D-4DEF-A070-94A674171C63Q40226623-4B549772-7ACA-4483-942A-D8FC87F5D7CD
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Tracy Robson
@ast
Tracy Robson
@en
Tracy Robson
@es
Tracy Robson
@nl
Tracy Robson
@sl
type
label
Tracy Robson
@ast
Tracy Robson
@en
Tracy Robson
@es
Tracy Robson
@nl
Tracy Robson
@sl
prefLabel
Tracy Robson
@ast
Tracy Robson
@en
Tracy Robson
@es
Tracy Robson
@nl
Tracy Robson
@sl
P106
P1153
7004843703
P21
P31
P496
0000-0003-4262-6872